IMUNON secures $10 million financing for ovarian cancer trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
IMUNON Announces Up to $10 Million Cash Financing
June 4, 2026 8:00 AM EDTIncludes up-front issuance of preferred stock for $2.5 million and securedÂ
promissory notes for $7.72 million
Uniquely structured, flexible financing supports IMUNONs Highly Anticipated Phase 3 OVATION 3 Study of IMNN-001 in advanced ovarian cancer
LAWRENCEVILLE, N.J., June 04, 2026 (GLOBE NEWSWIRE) --... More
